60
Participants
Start Date
October 27, 2022
Primary Completion Date
June 9, 2023
Study Completion Date
June 9, 2023
Relizema cram
Relizema cream is a CE marked, Class IIa medical device, dermatological cream for topical use indicated for symptomatic treatment of dermatitis and erythema. Relizema cream is indicated for the treatment of itching and flushing associated with different types of dermatitis, including atopic dermatitis.
Luca Stingeni, Perugia
Relife S.r.l.
INDUSTRY